Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT06200727
Other study ID # WDRY2022-K197
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date January 1, 2023
Est. completion date December 31, 2025

Study information

Verified date January 2024
Source Renmin Hospital of Wuhan University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to observe the role of PRF in treating ophthalmic diseases.The efficacy and safety of PRF were validated for four ophthalmic conditions: macular hole, pterygium, corneal ulcer, and patients undergoing trabeculectomy for glaucoma. The main question aims to answer is PRF's effectiveness in ocular surface and fundus diseases. Participants will be divided into 2 groups, the experimental group will be treated with PRF and the control group will be treated with conventional surgery, with a 12-month postoperative follow-up to determine the role of PRF on wound healing in ophthalmic diseases.


Description:

Patients suffering from pterygium, macular hole, corneal ulcer, and glaucoma requiring for trabeculectomy , who visited Renmin Hospital of Whuhan University, were chosen to participate in this study. The participants were randomly divided into the experimental group (PRF group) and the control group (conventional group). The PRF group received PRF membrane treatment, while the conventional group received conventional surgical treatment. Before and after surgery, participants underwent a comprehensive ophthalmological exam at 1 week, 1 month, 3 months, 6 months, and 12 months. The outcome indicators are monitored and can vary depending on the disease. Participants with pterygium were examined for graft dissolution and complications. Participants with macular hole were monitored for hole closure, visual acuity recovery, and retinal blood flow recovery. Participants with corneal ulcer were monitored for lesion healing and complications such as degree of corneal vascularization and opacity. Participants with glaucoma were monitored for postoperative intraocular pressure (IOP), degree of conjunctival leakage in the filtration zone, and degree of scarring in the filtration zone.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 170
Est. completion date December 31, 2025
Est. primary completion date June 30, 2025
Accepts healthy volunteers No
Gender All
Age group 20 Years to 90 Years
Eligibility Inclusion Criteria: 1. Diagnosis of macular hole confirmed by fundus examination; 2. Diagnosis of pterygium by slit lamp; 3. Patients requiring trabeculectomy for glaucoma; 4. Diagnosis of corneal ulcer confirmed by slit lamp. Exclusion Criteria: 1. Combination of other active ophthalmic diseases, such as acute conjunctivitis and uveitis; 2. Previous history of ophthalmic trauma and ophthalmic surgery; 3. Recent use of anticoagulant or antiplatelet drugs; 4. Combination of serious systemic diseases such as hypertension and diabetes mellitus.

Study Design


Intervention

Procedure:
PRF membrane tamponade surgery in macular hole
A specially formulated PRF membrane, as described previously, was filled into the macular hole to promote fissure repair.
ILM peeling in macular hole
The treatment of the macular hole was ILM peeling.
PRF membrane grafting in pterygium
Used of autologous PRF membrane to cover the exposed conjunctiva after pterygium excision.
Autologous conjunctival transplantation in pterygium
Used of autologous conjunctiva to cover exposed sclera after pterygium excision
autologous PRF membrane grafting in trabeculectomy for glaucoma
Used of autologous PRF membranes to cover the exposed sclera after trabeculectomy for glaucoma.
Amniotic membrane in trabeculectomy for glaucoma
Used of amniotic to cover the exposed sclera after trabeculectomy for glaucoma.
PRF membrane grafting incorneal ulcer
After surgical debridement of corneal ulcers, autologous PRF membrane was placed over the corneal wound to promote corneal healing
Amniotic membrane in corneal ulcer
After surgical debridement of corneal ulcers, autologous amniotic membrane was placed over the corneal wound to promote corneal healing

Locations

Country Name City State
China Eye Center, Renmin Hospital of Wuhan University Wuhan Hubei

Sponsors (1)

Lead Sponsor Collaborator
Lei Du

Country where clinical trial is conducted

China, 

References & Publications (2)

Yang N, Xing Y, Zhao Q, Zeng S, Yang J, Du L. Application of platelet-rich fibrin grafts following pterygium excision. Int J Clin Pract. 2021 Oct;75(10):e14560. doi: 10.1111/ijcp.14560. Epub 2021 Jul 5. — View Citation

Yang N, Zeng S, Yang J, Lu G, Du L. Application of Platelet-Rich Fibrin Transplantation for Large Macular Hole. Curr Eye Res. 2022 May;47(5):770-776. doi: 10.1080/02713683.2022.2029906. Epub 2022 Mar 22. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Whether the macular hole is closed in participants with macular hole(Unit: yes/no) Using optical coherence tomography(OCT )to see if the macular hole is healing to compare the healing rate between the PRF membrane filling group and the ILM peeling group. Pre-operation, and at 1 week, 1 month, 3 months, and 6 months post-operation.
Primary Whether the wound heals completely after pterygium excision in participants with pterygium(Unit: yes/no) Observation of the anterior segment of the eye using a slit lamp to determine whether the wound is healed after pterygium excision and to compare the healing rate between the PRF membrane-covered group and the autologous conjunctival-covered group. Pre-operation, and at 1 week, 1 month, 3 months, and 6 months post-operation.
Primary IOP in participants undergoing trabeculectomy for glaucoma(Unit: mmHg) Measurement of IOP using an IOP meter to compare the effect of IOP reduction in glaucoma treatment in the PRF membrane group and the amniotic membrane group. Pre-operation, and at 1 week, 1 month, 3 months, and 6 months post-operation.
Primary Whether the corneal ulcer is healing in participants with corneal ulcer(Unit: yes/no) The investigators use a slit lamp to examine the anterior segment of the eye to assess the corneal wound healing rate. The PRF membrane-covered group is compared to the control group. Pre-operation, and at 1 week, 1 month, 3 months, and 6 months post-operation.
Secondary Best-corrected visual acuity (BCVA) in participants with macular hole(Unit: logMAR) Measurement of BCVA in participants with macular holes using an international standard logarithmic visual acuity chart. Pre-operation, and at 1 week, 1 month, 3 months, and 6 months post-operation.
Secondary Occurrence of complications in participants with pterygium(Unit: rate) Using a slit lamp, visualizing the anterior eye segment to detect complications in participants with pterygium. Pre-operation, and at 1 week, 1 month, 3 months, and 6 months post-operation.
Secondary Degree of tissue scarification in participants undergoing trabeculectomy for glaucoma(Unit: mild, moderate, severe) Viewing the anterior segment of the eye using a slit lamp to determine the extent of tissue scarring in participants undergoing trabeculectomy for glaucoma. Pre-operation, and at 1 week, 1 month, 3 months, and 6 months post-operation.
Secondary Occurrence of complications in participants with corneal ulcer(Unit: rate) Using a slit lamp, visualizing the anterior eye segment to detect complications in participants with corneal ulcer. Pre-operation, and at 1 week, 1 month, 3 months, and 6 months post-operation.
See also
  Status Clinical Trial Phase
Recruiting NCT06000865 - Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE N/A
Recruiting NCT06278597 - Automatic Evaluation of the Anterior Chamber Angle Width by a New Non-contact Optical Device N/A
Active, not recruiting NCT04271709 - Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT) N/A
Recruiting NCT03274024 - The Asia Primary Tube Versus Trab (TVT) Study N/A
Completed NCT04552964 - Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma N/A
Recruiting NCT01957267 - Functional and Structural Imaging for Glaucoma
Active, not recruiting NCT04624698 - iStent Inject New Enrollment Post-Approval Study N/A
Completed NCT04020705 - The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma N/A
Completed NCT03150160 - Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma Phase 4
Not yet recruiting NCT05581498 - Glaucoma Exercise as Medicine Study (GEMS). N/A
Recruiting NCT02921568 - Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes N/A
Active, not recruiting NCT02901730 - Clinical Study of LPI With Different Laser Wavelengths N/A
Completed NCT02955849 - A Trial of China Laser and Surgery Study Glaucoma in Rural China Early Phase 1
Recruiting NCT02471105 - Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml Phase 4
Recruiting NCT02554214 - Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device N/A
Active, not recruiting NCT02390284 - Stop Retinal Ganglion Cell Dysfunction Study Phase 3
Completed NCT02520674 - Glaucoma Screening With Smartphone Ophthalmology N/A
Completed NCT02653963 - Triamcinolone for Ahmed Glaucoma Valve N/A
Completed NCT02390245 - Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study N/A
Completed NCT02246764 - Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension Phase 3